What's in MTI Medical Private Limited, Pakistan's pipeline?

MTI Medical Private Limited, Pakistan has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with MTI Medical Private Limited, Pakistan's portfolio?

Top competitors by shared drug class: National Taiwan University Hospital, Beijing 302 Hospital, Eli Lilly, Brooke Army Medical Center, Casa Sollievo della Sofferenza IRCCS.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/mti-medical-private-limited-pakistan.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

MTI Medical Private Limited, Pakistan — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MTI Medical Private Limited, Pakistan pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
RENESSANS , INTERFERON ALPHA 2b, Ribavirin	RENESSANS , INTERFERON ALPHA 2b, Ribavirin	phase 3	Antiviral combination therapy	Hepatitis C virus NS5B RNA polymerase; interferon alpha receptor signaling	Virology/Hepatology
RENESSANS	RENESSANS	phase 3	Antiarrhythmic	Unknown	Cardiovascular

Therapeutic area mix

Cardiovascular · 1
Virology/Hepatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

National Taiwan University Hospital · 2 shared drug classes
Beijing 302 Hospital · 1 shared drug class
Eli Lilly · 1 shared drug class
Brooke Army Medical Center · 1 shared drug class
Casa Sollievo della Sofferenza IRCCS · 1 shared drug class
Cliniques universitaires Saint-Luc- Université Catholique de Louvain · 1 shared drug class
Boehringer Ingelheim · 1 shared drug class
Ain Shams University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for MTI Medical Private Limited, Pakistan:

Cite this brief

Drug Landscape (2026). MTI Medical Private Limited, Pakistan — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/mti-medical-private-limited-pakistan. Accessed 2026-05-17.